Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Analyst Proficiency Testing – V 2.0

Posted on By

BA-BE Studies: SOP for Analyst Proficiency Testing – V 2.0

Standard Operating Procedure for Analyst Proficiency Testing in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/199/2025
Supersedes SOP/BA-BE/199/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a procedure for evaluating and documenting the technical competency of analysts involved in bioanalytical activities in BA/BE studies through scheduled proficiency testing in accordance with regulatory expectations.

2. Scope

This SOP is applicable to all analysts performing bioanalytical sample preparation, extraction, analysis, integration, and documentation activities in the Bioanalytical Laboratory for BA/BE studies.

3. Responsibilities

  • QA Officer: Coordinates the testing schedule and reviews results.
  • Lab
Manager: Assigns evaluators and approves proficiency evaluation outcomes.
  • Evaluator (Senior Analyst): Monitors and scores performance during testing.
  • Analyst: Participates in testing and follows protocols during evaluation.
  • 4. Accountability

    The Head of Bioanalytical Department is accountable for ensuring proficiency testing is performed consistently, and only qualified analysts perform regulated study analyses.

    5. Procedure

    5.1 Frequency of Proficiency Testing

    1. Conduct proficiency tests:
      • Annually for all analysts
      • During onboarding of new analysts
      • After a prolonged break (>3 months) or as part of CAPA
    2. Prepare a Proficiency Testing Calendar and maintain in Annexure-1.

    5.2 Components of Proficiency Test

    1. Test is designed to include:
      • Sample preparation (e.g., SPE, LLE)
      • Instrument operation (e.g., LC-MS/MS)
      • Chromatogram integration and peak review
      • Data documentation and raw data handling
    2. Test samples are spiked with known concentrations and analyzed in blinded format.

    5.3 Evaluation Criteria

    1. Analyst performance is scored on:
      • Accuracy: ±15% deviation from nominal values
      • Precision: %CV ≤ 15%
      • Adherence to SOPs and GLP documentation
    2. Use Annexure-2: Analyst Proficiency Scorecard for evaluation.

    5.4 Documentation and Review

    1. Document results, observations, and improvement recommendations in Annexure-3: Proficiency Testing Report.
    2. QA reviews and signs off on reports.
    3. Store reports in analyst training and competency file.

    5.5 Retraining and Corrective Action

    1. If an analyst fails to meet acceptance criteria:
      • Assign retraining on deficient areas
      • Repeat the proficiency test within 15 days
      • Restrict analyst from regulated studies until successful retesting
    2. Document all retraining sessions and corrective actions.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • BA/BE: Bioavailability/Bioequivalence
    • QA: Quality Assurance
    • CV: Coefficient of Variation
    • GLP: Good Laboratory Practice

    7. Documents

    1. Proficiency Testing Calendar – Annexure-1
    2. Analyst Proficiency Scorecard – Annexure-2
    3. Proficiency Testing Report – Annexure-3

    8. References

    • OECD Principles of GLP
    • ICH M10: Bioanalytical Method Validation
    • US FDA Bioanalytical Method Validation Guidance

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Proficiency Testing Calendar

    Analyst Name Scheduled Date Status Remarks
    Ajay Verma 10/03/2025 Completed Passed

    Annexure-2: Analyst Proficiency Scorecard

    Parameter Score Max Score Remarks
    Accuracy 14 15 Acceptable
    Instrument Operation 10 10 Excellent

    Annexure-3: Proficiency Testing Report

    Analyst Date Test Type Result Evaluator
    Sunita Reddy 12/03/2025 SPE & LC-MS/MS Pass Rajesh Kumar

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial release New competency program QA Head
    17/04/2025 2.0 Added scoring matrix and retesting flow Audit observation closure QA Head
    See also  BA-BE Studies: SOP for Creating Clinical Site Close-Out Checklist - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: API Manufacturing: SOP for QA Review of Environmental Monitoring Results – V 2.0
    Next Post: Creams: SOP for Conducting Internal Quality Audits for Cream Manufacturing – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version